Skip to content

Clinical trials

Phase 2 COVID-19 trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Phase: Phase 2 Country / region: South Korea Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20208
20214
20223
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated3
Unknown status2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bukwang Pharmaceutical2
Korea University Guro Hospital2
Shin Poong Pharmaceutical Co. Ltd.2
Asan Medical Center1
Cellid Co., Ltd.1
Chong Kun Dang Pharmaceutical1
Enzychem Lifesciences Corporation1
GeneOne Life Science, Inc.1
Green Cross Corporation1
ImmuneMed, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-1917
Coronavirus Infections2
Pneumonia1
Severe Acute Respiratory Syndrome1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.